|
|
SFX by Ex Libris Inc.
|
List of services to meet your request
|
||||||||||
|
||||||||||
© 2024 SFX by Ex Libris Inc. | Cookie Policy
CrossRef Omogočeno
![](https://beacon01.alma.exlibrisgroup.com/boom/apache_pb.gif?SRVR=adz.izum.si&IP=193.2.126.232&A=SFX&P=SFXMenu&S=sD226218E-5DE5-11EF-9099-584185CE164B&I=39IZM&T=&OP=Display&O=html&O1=15563748&O2=111006469463152&O3=&O4=summon.serialssolutions.com&O5=https%3A%2F%2Fadz.izum.si%2Fsfxlcl41%3Fctx_enc%3Dinfo%253Aofi%252Fenc%253AUTF-8%26ctx_ver%3DZ39.88-2004%26rfr_id%3Dinfo%253Asid%252Fsummon.serialssolutions.com%26rft.atitle%3DConsequences%2520of%2520immunogenicity%2520to%2520the%2520therapeutic%2520monoclonal%2520antibodies%2520ReoPro%2520and%2520Remicade%26rft.au%3DBarnathan%252C%2520E%26rft.au%3DOlson%252C%2520A%26rft.au%3DSchantz%252C%2520A%26rft.au%3DWagner%252C%2520C%2520L%26rft.date%3D2003-01-01%26rft.externalDocID%3D12762503%26rft.genre%3Darticle%26rft.issn%3D1424-6074%26rft.jtitle%3DDevelopments%2520in%2520biologicals%26rft.spage%3D37%26rft.volume%3D112%26rft_id%3Dinfo%253Apmid%252F12762503%26rft_id%3Dinfo%253Apmid%252F12762503%26rft_val_fmt%3Dinfo%253Aofi%252Ffmt%253Akev%253Amtx%253Ajournal&O6=1-MESSAGE_NO_FULLTXT_LCL-getMessageNoFullTxt-object,2-COBIB_SI_LCL-getHolding-object,3-ELSEVIER_SCOPUS_FIS_LCL-getAbstract-object,4-REFWORKS_EXPORT_TOOL-getReference-object,5-NCBI_PUBMED_FREE-getCitedRecord-object,6-GOOGLE_SCHOLAR_FREE-getWebSearch-object,7-WWW_SEARCH_ENGINES_FREE-getWebSearch-object&O7=1.230104&O8=N&O9=<ctx:context-object identifier="urn:sfxstat:15563748-sD226218E-5DE5-11EF-9099-584185CE164B" timestamp="2024-08-19T06:45:15Z" xmlns:ctx="info:ofi/fmt:xml:xsd:ctx">
<ctx:referent>
<ctx:identifier>urn:sfxid:111006469463152</ctx:identifier>
<ctx:metadata-by-val>
<ctx:format>info:ofi/fmt:xml:xsd:journal</ctx:format>
<ctx:metadata>
<jnl:journal xmlns:jnl="info:ofi/fmt:xml:xsd:journal">
<jnl:atitle>Consequences of immunogenicity to the therapeutic monoclonal antibodies ReoPro and Remicade.</jnl:atitle>
<jnl:jtitle>Developments in biologicals</jnl:jtitle>
<jnl:date>2003-00-00</jnl:date>
<jnl:spage>37</jnl:spage>
<jnl:epage>53</jnl:epage>
<jnl:coden>DBEIAI</jnl:coden>
<jnl:issn>1424-6074</jnl:issn>
<jnl:volume>112</jnl:volume>
<jnl:genre>article</jnl:genre>
<jnl:eissn>1662-2960</jnl:eissn>
<jnl:language>eng</jnl:language>
<jnl:coden>DBEIAI</jnl:coden>
<jnl:authors></jnl:authors>
</jnl:journal>
</ctx:metadata>
</ctx:metadata-by-val>
</ctx:referent>
<ctx:requester>
<ctx:identifier>urn:ip:fde3c8730e09098319fa72ac7c94436364f1c608</ctx:identifier>
<ctx:identifier>urn:UUID:sD226218E-5DE5-11EF-9099-584185CE164B</ctx:identifier>
</ctx:requester>
<ctx:referrer>
<ctx:identifier>info:sid/summon.serialssolutions.com</ctx:identifier>
</ctx:referrer>
<ctx:service-type>
<ctx:metadata-by-val>
<ctx:format>info:ofi/fmt:xml:xsd:svcList</ctx:format>
<ctx:metadata>
<svc:svcList xmlns:svc="http://www.exlibrisgroup.com/schema/info:ofi/fmt:xml:xsd:sch_svc"></svc:svcList>
</ctx:metadata>
</ctx:metadata-by-val>
</ctx:service-type>
<ctx:resolver>
<ctx:identifier>https://adz.izum.si/sfxlcl41</ctx:identifier>
</ctx:resolver>
</ctx:context-object>
&)